Evidence map›Paper›PMID 36951238›Full record

ArticleGlia2023

Microglia play beneficial roles in multiple experimental seizure models.

Synphane Gibbs-Shelton, Jordan Benderoth, Ronald P Gaykema, Justyna Straub, Kenneth A Okojie, Joseph O Uweru, Dennis H Lentferink, Binita Rajbanshi, Maureen N Cowan, Brij Patel and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Glia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. In conversation with Ukpong Eyo.Nature neuroscience · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Synphane Gibbs-SheltonBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Jordan BenderothBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Ronald P GaykemaDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Justyna StraubDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Kenneth A OkojieBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Joseph O UweruBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Dennis H LentferinkBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Binita RajbanshiDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Maureen N CowanBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Brij PatelBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Anthony Brayan Campos-SalazarBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.
Edward Perez-ReyesDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Ukpong B EyoBrain Immunology and Glia Center, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-1294-475X
University of Virginia · US

Funding

TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
Microglial-Neurovascular Dynamics and Regulation of Neurovascular Structure and FunctionR01NS122782 · NINDS · UNIVERSITY OF VIRGINIA · PI EYO, UKPONG BASSEY · 2021 to 2025
$2.0M
Training in the Pharmacological SciencesT32GM148379 · NIGMS · UNIVERSITY OF VIRGINIA · PI Michelle L Bland, Thurl E. Harris · 2023 to 2026
$1.3M
Validation of a Novel Mouse Model of Temporal Lobe EpilepsyR33NS112549 · NINDS · UNIVERSITY OF VIRGINIA · PI PEREZ-REYES, EDWARD · 2022 to 2022
$407k
NIGMS NIH HHS T32 GM007055NIGMS NIH HHS T32 GM148379NINDS NIH HHS R01 NS122782NINDS NIH HHS R33 NS112549
6 · The paper itself

Abstract

Seizure disorders are common, affecting both the young and the old. Currently available antiseizure drugs are ineffective in a third of patients and have been developed with a focus on known neurocentric mechanisms, raising the need for investigations into alternative and complementary mechanisms that contribute to seizure generation or its containment. Neuroinflammation, broadly defined as the activation of immune cells and molecules in the central nervous system (CNS), has been proposed to facilitate seizure generation, although the specific cells involved in these processes remain inadequately understood. The role of microglia, the primary inflammation-competent cells of the brain, is debated since previous studies were conducted using approaches that were less specific to microglia or had inherent confounds. Using a selective approach to target microglia without such side effects, we show a broadly beneficial role for microglia in limiting chemoconvulsive, electrical, and hyperthermic seizures and argue for a further understanding of microglial contributions to contain seizures.

Indexed as

EpilepsyMicrogliaBrainHumansSeizuresCSF1RinflammationkindlingmicrogliaPLX3397seizures

Identifiers

PMID36951238
PMCPMC12706759
OpenAlexW4360600127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.